← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2015Last known activity
Sep 30, 2025
Timeline
2010s
- Jan 1, 2014
Alliance Foundation Trials— Founded
Drugs by trial phase (45 distinct, 22 trials)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
- Arteritis
- Arthritis
- Arthritis, Rheumatoid
- Autoimmune Diseases
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Colitis
- Colitis, Ulcerative
- Crohn Disease
- Endometrial Neoplasms
- Giant Cell Arteritis
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Mantle-Cell
- Multiple Myeloma
- Multiple Sclerosis
- Neoplasms, Plasma Cell
- Polymyalgia Rheumatica
- Prostatic Neoplasms
- Psoriasis
- Sclerosis
- Small Cell Lung Carcinoma
- Triple Negative Breast Neoplasms
Recent trials (37)
- NCT07149363Lead sponsorPhase 2Sep 30, 2025
- NCT07149363OfficialPhase 2Sep 30, 2025
- NCT05798663Lead sponsorPhase 2Dec 7, 2023
- NCT05633654CollaboratorPhase 3Dec 12, 2022
- NCT05408026Lead sponsorPhase 1/Phase 2Oct 1, 2022
- NCT05207709CollaboratorPhase 3Mar 28, 2022
- NCT04720157CollaboratorPhase 3Jun 9, 2021
- NCT04486352Lead sponsorPhase 1/Phase 2Sep 30, 2020
- NCT04335682Lead sponsorPhase 2May 31, 2020
- NCT04335682Overall official - principal investigatorPhase 2May 31, 2020
- NCT04009109Lead sponsorPhase 2Oct 1, 2019
- NCT04009109Overall official - principal investigatorPhase 2Oct 1, 2019
- NCT04062708Overall official - principal investigatorPhase 2Sep 30, 2019
- NCT04062708Lead sponsorPhase 2Sep 30, 2019
- NCT03702725Lead sponsorPhase 1Jul 1, 2019
Details
- Founded
- Boston, MA, US Jan 1, 2014
- Last known activity
- Sep 30, 2025